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ABSTRACT
Objective: Idiopathic dilated cardiomyopathy (IDC) impairs and reduces coronary flow reserve (CFR). High level of red cell distribution width 
(RDW) is an independent risk factor for cardiovascular diseases. Therefore, in this observational case-control study we have aimed to deter-
mine whether RDW level is associated with CFR impairment in patients with IDC.
Methods: We examined 36 patients with IDC and 35 healthy subjects formed as a control group. In addition to this, patients with IDC were 
divided into two subgroups according to their CFR levels [normal CFR group (CFR value ≥2) and lower CFR group (CFR value<2)]. Control and 
patients groups were compared using the student t-test for multiple comparisons. The subgroups were compared using the Mann-Whitney U 
test for continuous variables and chi-square for categorical variables. The Pearson’s and Spearman correlation analysis was used to test the 
possible associations between CFR and the study variables as appropriate. The receiver-operating characteristic (ROC) curve was determined 
to evaluate the predictive performance of RDW to detect low CFR.
Results: There were no significantly differences between the lower and higher CFR groups’ clinical data, baseline hemodynamic, medication and 
biochemical data except RDW and high-sensitivity C-reactive protein levels. We found that RDW level was a good predictor of low CFR at the 
receiver-operating characteristic curve. The area under the curve (AUC) was 73% (95% confidence interval between 0.56-0.90 is 95%, p: 0.018) 
After adjusting potential confounders include age, body-mass index, blood pressure, lipid and glucose, RDW independently associated with CFR 
level (Beta:-0.374; p=0.015) and hsCRP value (Beta:-0.520; p=0.001) were the independent predictors of lower CFR.
Conclusion: Results showed that there was an independent correlation between RDW level and CFR level in patients with IDC. 
(Anadolu Kardiyol Derg 2014; 14: 342-8)
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Introduction
The RDW is a marker of variation of the size of the circulating 
red blood cells. RDW is widely available, inexpensive and included 
in blood panel. Studies have been reported that the elevated RDW 
levels are associated with poor prognosis in the setting of stable 
angina (1, 2), acute myocardial infarction (3, 4), heart failure (5, 6), 
stroke (7), peripheral arterial disease (8), older age (9) and in the 
patient without coronary artery disease (10, 11). One study dem-
onstrated that high RDW values are associated with an increased 
risk of all-cause mortality in the intensive care unit (12). RDW also 
predicts left ventricular ejection fraction, heart failure (HF) diag-
nosis and readmission for HF among coronary artery disease 
(CAD) patients (13). Thus, RDW seems to be a strong and indepen-
dent predictor of mortality in a wide range of population of cardio-
vascular patients across a spectrum of risk (14).
Higher levels of RDW may reflect an underlying inflammatory 
state, which is associated with adverse clinical outcomes and 
lead to impaired erythrocyte maturation. Several investigators 
have reported that oxidative stress is implicated in the pathogen-
esis and progression of heart failure. Recent experimental and 
clinical studies have revealed that reactive oxygen species (ROS) 
are produced in the failing myocardium and that ROS induces the 
functional and structural damage of cardiomyocytes (15, 16).
CFR reflects coronary microvascular function. Despite the 
fact that coronary artery is normal, CFR is altered in patient with 
IDC due to coronary microcirculatory dysfunction. Reduced CFR 
has been reported to be a poor prognostic indicator in patients 
with idiopathic left ventricle dysfunction (17). However, the 
mechanism of reduced CFR in IDC is not fully understood. 
Studies have shown that CFR measured by transthoracic sec-
ond harmonic Doppler echocardiography (TTDE) has an excel-
lent correlation with CFR measured by position emission tomog-
raphy (18). Studies reported that there was an important and 
highly significant correlation between CFR and myocardial cap-
illary density in patients with IDC.
 In previous studies, although it was shown that high levels 
of RDW is the prognostic marker in heart failure cases, there 
was no data indicating the correlation between RDW and CFR in 
patients with IDC. For this reason, in the present study we 
hypothesized that subclinical inflammation, oxidative stress and 
increased RDW in IDC patients might affect coronary microcir-
culation and impairs myocardial contractile function. Therefore, 
we aimed to investigate whether there is a relationship between 
coronary flow reserve and RDW levels in patient with IDC. 
Methods
Study population
Thirty six patients with IDC and 35 healthy subjects were 
enrolled in this study. This an observational study was per-
formed June 2008 and November 2013 at the cardiology and 
heart and vascular surgery department of Başkent University 
Training and Research Center in Konya, Turkey. 
Study design
In an observational case-control study, patients with IDC 
were divided into two subgroups according to their CFR levels. To 
exclude the patients with IDC caused by ischemic heart disease 
we applied coronary angiography to all patients before the study. 
They have normal epicardial coronary arteries without any wall 
irregularities. Functional capacity of patients were class I-III 
according to New York Heart Association (NYHA) functional 
class. Left ventricular (LV) ejection fraction (LVEF) was less than 
45% by echocardiography and left ventriculography. All patients 
were diagnosed as IDC at least before 6 months and treated with 
beta blocker, ACE inhibitor and diuretic agents. All patients were 
clinically stabilized under these treatments and had normal sinus 
rhythm at the time of study. Exclusion criteria were the following; 
any identifiable reason that might cause dilated cardiomyopathy, 
a valvular or congenital heart disease, cardiac rhythm other than 
sinus; chronic obstructive pulmonary diseases or cor pulmonale, 
chronic renal failure (serum creatinine >1.8 mg/dL), excessive 
alcohol consumption (>120 g/day) and smoking. Moreover, 
patients with any condition which can cause coronary microvas-
cular dysfunction such as hemolytic, hepatic, inflammatory, auto-
immune, coronary artery disease, diabetes mellitus, hyperten-
sion, hyperlipidemia, smoking, having triglyceride levels greater 
than 4.56 mmol/L (400 mg/dL), BMI greater than 35 kg/m2, or left 
ventricular mass index (LVMI) of 125 g/m2 or more for men and 
110 g/m2 or more for women were excluded. 
Study variables
Biochemical analyses
Blood samples were drawn from antecubital vein at 08:00-
10:00 AM after a fasting time period of 12 hours. An automatic 
blood counter was used. Blood samples were collected in dipo-
tassium EDTA tubes. The measurements were performed within 
30 minutes after sampling. Total cholesterol, high-density lipopro-
tein (HDL), low-density lipoprotein (LDL) and triglyceride were 
measured by enzymatic methods. Plasma levels of high sensitiv-
ity C-reactive protein (hsCRP) were measured with a highly sen-
sitive sandwich ELISA technique. Serum RDW levels determined 
using the (Cell-Dyne 3700, Abbott, Abbott Park, IL, USA). 
Echocardiographic examination
Each subject was examined using an Acuson Sequoia C256 
Echocardiography System equipped with 3V2c and 5V2c high-
resolution transducers with second harmonic capability 
(Acuson, Mountain View, CA, USA). Each subject underwent 
2-dimensional, M-mode, and subsequent standard and pulsed 
tissue Doppler echocardiographic examinations. The echocar-
diographic images were recorded on VHS videotapes. Diastolic 
and systolic interventricular septal (IVS) thickness, posterior 
wall (PW) thickness, and left ventricular end-diastolic diameter 
(LVEDD), and left ventricular end-systolic diameter (LVESD) 
were measured on the parasternal long-axis views, and left 
ventricular mass was calculated according to the formula below 
(19): LVM=0.8x(1.04[(IVSd+PWd+LVEDD)3-(LVEDD)3])+0.6g. All 
measurements were performed on M-mode images. The pulsed 
Doppler sample volume was positioned at the mitral leaflet tips. 
Early diastolic peak flow velocity (E), late diastolic peak flow 
velocity (A) and E/A ratio, and E wave deceleration time (DT) 
were measured from transmitral Doppler spectra. All diastolic 
parameters were measured in 3 consecutive cardiac cycles and 
averaged. The same-blinded investigator performed the echo-
cardiography, and two blinded cardiologists analyzed the echo-
cardiogram recordings. 
CFR measurement
Visualization of the distal left anterior descending (LAD) coro-
nary artery was performed using a modified, foreshortened, two-
chamber view obtained by sliding the transducer on the upper 
part and medially from an apical two-chamber view to reach the 
best alignment to the interventricular sulcus. Subsequently, coro-
nary flow in the distal LAD was examined by color Doppler flow 
mapping over the epicardial part of the anterior wall, with the 
color Doppler velocity range of 8.9-24.0 cm/s. The color gain was 
adjusted to provide optimal images. The acoustic window was 
placed at approximately the midclavicular line, in the fourth and 
fifth intercostal spaces, with the subject in the left lateral decu-
bitus position (20). The left ventricle was imaged on the long-axis 
cross-section, and the ultrasound beam was then inclined later-
ally. Next, coronary blood flow in the LAD (middle to distal) was 
searched by color Doppler flow mapping. All subjects had 
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Doppler recordings of the LAD with a dipyridamole infusion at 
rate of 0.56 mg/kg over 4-6 min. Coronary diastolic peak velocities 
were measured at baseline and after dipyridamole infusion by 
averaging the highest 3 Doppler signals for each measurement. 
CFR was defined as the ratio of hyperemic to baseline diastolic 
peak velocities. CFR ≥2.0 was considered normal (20). To test the 
coefficient of repeatability of the CFR measurement, in 10 control 
subjects the measurement was repeated 2 days later. 
Intraobserver intraclass correlation coefficient for coronary flow 
measurement was 0.847, and for CFR value it was 0.903.
Our institutional Ethics Committee approved the study proto-
col and each subject provided written informed consent.
Statistical analyses
All analyses were conducted using SPSS 9.0 (SPSS for 
Windows 9.0, Chicago, IL, USA). All group data are expressed as 
mean±standard deviation. The two groups were compared 
using the Student t-test for multiple comparisons. The sub-
groups were compared using the Mann-Whitney U test for 
continuous variable and chi-square for categorical variables. 
The Pearson’s and Spearman correlation [fasting glucose, 
hsCRP, RDW, uric acid, blood urine nitrogen (BUN), creatinine 
and left ventricular EF] analysis was used to test the possible 
associations between CFR and the study variables as appropri-
ate. Prediction of variables was obtained by stepwise, regres-
sion including potential confounders (RDW, hsCRP, uric acid, 
BUN, creatinine and left ventricular EF). The receiver-operating 
characteristic (ROC) curve was determined to evaluate the pre-
dictive performance of RDW to detect low CFR. The area under 
the ROC curve (AUC) and its standard error were calculated. A 
p value of <0.05 was considered significant. 
Results
The general features and risk factors for coronary artery 
disease of the study population are demonstrated in Table 1. 
There was no significantly difference between the control and 
patient groups in regard to age, sex, BMI, heart rate, systolic 
blood pressure (BP), diastolic BP, lipid profiles (except total cho-
lesterol level), hemoglobin and fasting blood glucose levels. 
However, high-sensitivity C-reactive protein levels were notably 
higher in the patients with IDC than those in the control group 
(3.52±2.17 vs. 1.94±1.37, p=0.006). Similarly, RDW ratio was statis-
tically higher in patients with IDC than that in controls (16.14±1.83 
vs. 15.11±0.96, p=0.030). Serum uric acid (5.98±2.26 vs. 4.21±1.12, 
p=0.001) and creatinine levels (1.02±0.29 vs. 0.87±0.11, p=0.017) 
were also significantly higher in patients with IDC than those in 
the control group. 
As shown in Table 2, LVEDV and LVESV were notably higher 
in patients with IDC; Left ventricular EF was significantly lower 
in patients with IDC. LVMI was fairly higher in the IDC group 
compared to the controls. Echocardiographic diastolic function 
measurements (except mitral A-wave max), heart rate and blood 
pressure values were comparable between the two groups. 
Heart rate and blood pressure responses to dipyridamole infu-
sion were alike between two groups. Baseline DPFV (diastolic 
peak flow velocity) (27.2±7.1 vs. 22.2±2.8, p=0.001) was signifi-
cantly higher and hyperemic DPFV (55.7±14.5 vs. 68.9±13.4, 
p=0.001) values were greatly lower in the IDC group compared to 
the controls. Therefore, statistically CFR was significantly lower 
in the IDC group (2.06±0.37 vs. 3.09±0.47, p=0.001).
 According to the median value of CFR (2.0) the patients were 
divided into two groups; the lower CFR group (<2.0) and the nor-
mal CFR group (≥2.0). The demographic, biochemical and echo-
cardiographic characteristics of two groups are summarized in 
Table 3. RDW levels were significantly higher in the lower CFR 
group than those in the normal CFR group (15.3±0.9 vs. 16.9±2.1, 
p=0.009). Left ventricular diastolic functions parameters were 
not significantly different in two groups. Baseline blood pres-
sures were similar between the groups. Left ventricular EF was 
quite lower in the impaired CFR group than those in the normal 
CFR group (Table 4).
  Subjects with  Healthy 
  IDC controls
  (n=36) (n=35) P
Clinical data   
 Age, year 56.6±11.3 55.2±6.8 0.50
 Male/female, % 20/16  18/17  0.43
 Body-mass index, kg/m2 27.2±4.4 27.7±1.5 0.58
Baseline hemodynamics   
 Systolic BP, mm Hg 120.6±12.3 122.0±12.7 0.64
 Diastolic BP, mm Hg 77.4±7.1 75.6±6.0 0.25
 Heart rate, beats/min 71.2±12.6 73.8±10.5 0.37
Hematological and biochemical data  
 Total-cholesterol, mg/dL 170.7±37.8 190.3±27.4 0.02
 HDL-cholesterol, mg/dL 42.0±6.7 42.8±9.6 0.65
 LDL-cholesterol, mg/dL 106.9±35.0 115.5±19.5 0.21
 Triglyceride, mg/dL 133.5±59.9 140.8±61.7 0.62
 Glucose, mg/dL 96.7±10.4 93.5±4.9 0.24
 hsCRP, mg/Lγ 3.52 (0.27-9.6) 1.94 (0.55-5.86) 0.006
 Hemoglobin, g/dL 14.04±1.05 14.47±0.76 0.06
 RDW, %γ 16.14 (13.5-22.6) 15.11 (13.5-17.0) 0.03
 BUN, mg/dLγ 17.02 (10-36) 16.54 (9.0-24) 0.22
 Creatinin, mg/dLγ 1.02 (0.6-2) 0.87 (0.67-1.10) 0.017
 Uric acid, mg/dLγ 5.98 (2.6-12.5) 4.21 (2.5-7.9) 0.001
Statistics: The two groups were compared using the Student t-test or γMann-Whitney U 
test for multiple comparisons 
BP - blood pressure;  BUN - blood urea nitrogen; HDL - high-density lipoprotein; hsCRP - 
high-sensitivity C -reactive protein; IDC-idiopathic dilated cardiomyopathy; LDL - low-
density lipoprotein; RDW - red cell distribution width; RDW - red cell distribution width
Table 1. Demographic and biochemical characteristics, blood pressure 
values and medications in patients with IDC and control subjects
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Hemoglobin, hematocrit, white blood cells were not different 
in the groups. However, patients with lower CFR had signifi-
cantly higher RDW ratio as compared to patients with normal 
CFR, respectively. In addition, CFR is significantly and inversely 
correlated to RDW levels. We have no findings which show that 
patients with impaired CFR have different total cholesterol, LDL 
cholesterol and triglyceride values. hsCRP values were higher in 
the lower CFR group (2.7±1.5 vs. 4.3±2.4; p=0.03). CFR is signifi-
cantly and inversely correlated to RDW level, serum uric acid, 
creatinine and hsCRP. Furthermore, in stepwise linear regression 
analysis, when CFR was taken as dependent, and RDW and 
other study variables including serum uric acid, BUN, creatinine 
and hsCRP, left ventricular EF as independent, we found that 
RDW value (Beta:-0.374, p=0.015) and hsCRP levels (Beta:-0.520, 
p=0.001) were significantly associated with CFR (Table 5). We 
also showed that RDW level was an accurate predictor of low 
CFR on the receiver operating characteristic (ROC) curve (Fig. 1). 
The area under the curve (AUC) was 73% (95% confidence inter-
val 0.56-0.90), and RDW levels were significantly predictive of 
low CFR (p=0.018). In addition, RDW significantly and positively 
correlated with serum uric acid (r=0.546, p=0.001) and BUN lev-
els (r=0.471, p=0.005).
Discussion
In this study, we found that IDC patients have decreased 
CFR, increased RDW, uric acid and hsCRP compared to healthy 
controls. Previous studies revealed that coronary microvascular 
dysfunction, oxidative stress (as a surrogate marker of uric 
acid), subclinical inflammation, and increased RDW might take 
part in the development of myocardial contractile dysfunction (3, 
21). In this respect, our results are consistent with the previous 
published data. Differing from the previous one, in this study we 
have searched for a possible role of increased RDW and serum 
uric acid levels, and whether subclinical inflammation might 
negatively contribute or not to impaired coronary microvascular 
function in patients with IDC. Hence, the patients with IDC were 
divided into two groups based on the median value of CFR, with 
the cut-off point two. The main findings of the study were that 
IDC patients with lower CFR had increased RDW, hsCRP and 
serum uric acid levels. Also it was evident that there was inde-
pendent association between RDW levels and CFR in patients 
with IDC. To our knowledge this is the first study showing the 
  Subjects with  Healthy 
  IDC  controls
  (n=36) (n=35) P
LVEDV, mL 199.6±64.5 87.1±8.4 0.001
LVESV, mL 129.0±51.9 35.6±6.7 0.001
EF, %γ 35.6 (23-44) 66.9 (63-70) 0.001
LVMI, g/m2 148.3±33.9 80.0±11.3 0.001
Mitral E-wave max, cm/s 70.3±26.3 77.5±12.6 0.14
Mitral A-wave max, cm/s 66.8±25.5 60.1±11.3 0.03
E/A ratio 1.48±1.44 1.31±0.21 0.64
Mitral E-wave  209.9±74.9 187.3±17.1 0.09 
deceleration time, ms 
Heart rate at rest, beats/min 70.8±12.6 73.5±12.3 0.23
Systolic BP at rest, mm Hg 120.6±12.3 122.0±12.6 0.64
Diastolic BP at rest, mm Hg 77.3±7.1 75.5±6.0 0.25
Heart rate after  94.4±11.4 98.3±12.9 0.18 
dipyridamole, beats/min 
Systolic BP after  118.0±12.7 119.2±7.3 0.61 
dipyridamole, mm Hg 
Diastolic BP after  75.5±6.4 76.1±5.5 0.69 
dipyridamole, mm Hg 
Baseline DPFV, cm/s 27.2±7.1 22.2±2.8 0.001
Hyperemic DPFV, cm/s 55.7±14.5 68.9±13.4 0.001
CFR ratio 2.06±0.37 3.09±0.47 0.001
Statistics: The two groups were compared using the Student t-test or γ Mann-Whitney 
U test for multiple comparisons 
BP - blood pressure; CFR - coronary flow reserve; DPFV - diastolic peak flow velocity; 
EF - ejection fraction; IDC-idiopathic dilated cardiomyopathy; LA - left atrium;  
LVEDV - left ventricular end-diastolic volume; LVESV - left ventricular end systolic 
volume; LVMI - left ventricular mass index
Table 2. Echocardiographic findings, and standard Doppler parameters 
of the left ventricle, coronary flow velocities and CFR values in 
patients with IDC and control subjects
  IDC patients  IDC patients 
  with CFR ≥2  with CFR <2
  (n=18) (n=18)  P
Age, year 57.3±9.7 56.0±12.9 
Body-mass index, kg/m2 27/22 24/24 0.68
Systolic BP, mm Hg 26.6±3.9 27.8±4.8 0.78
Diastolic BP, mm Hg 116.9±8.5 124.4±14.5 0.09
Heart rate, bpm 73.4±9.1 71.4±8.1 0.27
Total cholesterol, mg/dL 168.7±40.9 172.8±35.4 0.95
HDL-cholesterol, mg/dL 40.5±5.5 43.5±5.9 0.09
LDL-cholesterol, mg/dL 104.3±28.2 109.4±41.5 0.98
Triglyceride, mg/dL 133.4±62.8 131.0±57.5 0.79
Hemoglobin, g/dL 14.0±1.1 14.0±1.0 0.81
hsCRP, mg/L 2.7±1.5 4.3±2.4 0.03
Glucose, mg/dL 95.4±12.1 97.8±8.8 0.48
BUN, mg/dL 15.4±4.0 18.8±8.9 0.17
Creatinine, mg/dL 0.93±0.22 1.11±0.32 0.07
Uric acid, mg/dL 4.9±1.1 7.0±2.6 0.013
RDW, % 15.3±0.9 16.9±2.1 0.009
Statistics: Mann-Whitney U test was used for continuous variables and chi-square for 
categorical variables 
bpm - beat per minute; BP - blood pressure; BUN - blood urea nitrogen; CFR - coronary flow 
reserve; HDL - high-density lipoprotein; hsCRP - high-sensitivity C-reactive protein; IDC-idiopathic 
dilated cardiomyopathy; LDL - low-density lipoprotein; RDW - red cell distribution width
Table 3. Baseline clinical characteristics and laboratory analysis of 
study populations
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presence of independent association between RDW and CFR in 
patients with IDC.
The red cell distribution width (RDW) is a marker of variation 
of the size of the circulating red blood cells. RDW is also defined 
as the standard deviation of erythrocyte size divided by the mean 
corpuscular volume (MCV) (22). MCV and RDW can help together 
to differentiate the several etiologies of anemia. RDW increases 
in iron deficiency, B12 or folate deficiency, also in hemoglobin-
opathies, hemolysis and after blood transfusions (15-17). 
Furthermore, a number of studies have been reported that the 
elevated RDW levels are associated with poor prognosis in the 
setting of stable angina (1, 2), acute myocardial infarction (3, 4), 
heart failure (5, 6), stroke (7), peripheral arterial disease (8), older 
age (9) and in the patients without CAD (10, 11). Chen at al. (11) 
concluded that high RDW values are associated with increased 
danger of all-cause mortality but not with the development of 
cardiovascular mortality in patients without CAD. On the other 
hand, Perlstein et al. (10) demonstrated that RDW strongly pre-
dicted the all-cause and cardiovascular mortality in a large, com-
munity based sample. Felker et al. (14) were the first to report the 
excess mortality and morbidity in patient with chronic heart fail-
ure and elevated RDW. In another study, Allen et al. (23) also 
showed that RDW is significantly associated with adverse out-
come in chronic HF and they suggested that the elevated RDW 
may indicate inflammatory stress and impaired iron mobilization. 
Correlation between RDW and cardiovascular diseases is as the 
following; in cardiovascular diseases inflammatory cytokines 
and neurohumoral mediators become activated. This causes 
suppressing the maturation of erythrocytes. Therefore, the 
increase in immature erythrocytes raises RDW levels (24). 
In spite of angiographically normal coronary arteries, owing 
to coronary microvascular dysfunction CFR is impaired in patients 
with IDC (25). The association between hsCRP and coronary 
endothelial and/or microvascular dysfunction is evident. In our 
study, hsCRP levels were significantly higher in the patients with 
IDC than those in the control group. Also we found an important 
correlation between hsCRP and CFR in IDC patients. Chronic 
subclinical inflammatory state has been found to precede 
  IDC patients  IDC patients 
  with CFR ≥2  with CFR <2
  (n=18) (n=18)  P
LVEDV, mL 186.0±44.0 213.2±79.1 0.47
LVESV, mL 116.8±45.9 141.1±56.2 0.19
LA diameter, cm 3.32±0.30 3.33±0.28 0.76
EF, % 37.5±6.8 33.7±6.1 0.05
LVMI, g/m2 145.4±32.9 151.5±35.6 0.86
Mitral E max, cm/s 63.3±24.4 77.4±26.9 0.09
Mitral A max, cm/s 66.7±25.1 66.9±26.7 0.94
E/A ratio  1.23±1.31 1.76±1.56 0.16
Mitral E deceleration time, s 108.8±17.9 118.3±24.8 0.44
Baseline heart rate, bpm 73.2±6.9 72.1±11.2 0.47
Baseline systolic BP, mm Hg 148.9±8.4 150.1±7.3 0.24
Baseline diastolic BP, mm Hg 91.8±4.3 90.1±4.9 0.63
Peak heart rate, bpm 91.4±13.6 87.8±16.7 0.51
Peak systolic BP, mm Hg 116.1±11.3 119.7±13.9 0.50
Peak diastolic BP, mm Hg 74.6±5.0 76.5±7.5 0.35
Baseline DPFV, cm/s 25.8±4.9 28.7±8.7 0.38
Hyperemic DPFV, cm/s 60.3±14.1 51.1±13.7 0.06
CFR ratio 2.34±0.31 1.79±0.20 0.001
Statistics: Mann-Whitney U test was used for continuous variables and chi-square for 
categorical variables. 
bpm - beat per minute; BP - blood pressure; CFR - coronary flow reserve; DPFV - 
diastolic peak flow velocity; EF - ejection fraction; IDC-idiopathic dilated 
cardiomyopathy; LA - left atrium; LVEDV - left ventricular end-diastolic volume; LVESV 
- left ventricular end systolic volume; LVMI - left ventricular mass index
Table 4. Data from echocardiographic examinations of the study 
subject
 Bivariate correlation Multiple regression
 Pearson r P value β P value
RDW, % -0.477 0.001 -0.374 0.001
hsCRP, mg/dL -0.537 0.001 -0.520 0.015
Uric acid, mg/dL -0.427 0.029 - -
EF, % 0.168 0.21 - -
BUN, mg/dL -0.327 0.18 - -
Creatinin, mg/dL -.0352 0.03 - -
Statistics - The Pearson’s and Spearman correlation (hsCRP, uric acid, BUN, creatinine 
and left ventricular EF) and stepwise regression analysis was performed. 
BUN - blood urea nitrogen; EF - ejection fraction; hsCRP - high-sensitivity C-reactive 
protein; RDW - red cell distribution width
Table 5. Correlation and regression analysis in patients with IDC
Figure 1. ROC curve analysis of RDW levels for low CFR
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adverse cardiovascular outcome and hsCRP has been found to 
be a surrogate marker of inflammation (26). On the other hand, a 
strong positive correlation between RDW and markers of inflam-
mation such as interleukin-6 and C-reactive protein (27). Also in 
our study, although it is poor we found a positive correlation 
between RDW and hsCRP in patients with IDC. Zalawadiya et al. 
(28) reported that in patients with HF taking statins RDW is lower. 
Anti-atherogenic property of statins has been shown via modu-
lating inflammation and stabilizing atherosclerotic plaque. One 
could speculate that the inverse relation between the use of 
statin and RDW may be secondary to the anti-inflammatory prop-
erty of statins, which further supports RDW as a marker of 
chronic inflammation in patients with IDC. Long-term treatment 
with beta blocker (carvedilol) can significantly increase coronary 
flow reserve and reduce the occurrence of stress-induced per-
fusion defects, suggesting a favourable effect of the drug on 
coronary microvascular function in patients with IDC (29). The 
known effects of β-blocking agents in heart failure includes 
reversing LV remodelling, increasing myocardial oxygen to sup-
ply ratio, additional mechanisms associated with vasodilatory 
and antioxidant properties. Furthermore, anti-inflammatory 
effects of beta blocker (carvedilol) and ACE inhibitor have been 
described. Though all the patients were treated with the same 
treatment it wasn’t completely explained why the level of some 
patients’ RDW is high and that of their CFR’s is low.
Studies suggest that oxidative stress might be involved in the 
pathogenetic processes in heart failure and myocardial oxida-
tive stress and inflammation increase in hypertrophied or failing 
myocardium (30-32). Red blood cells (have a huge antioxidant 
capacity and serve as a primary oxidative sink, but they are 
prone to oxidative damage, which reduces cell survival and 
induces the release of immature erythrocytes into circulation 
(33). Altered CFR has been described in patients with dilated 
cardiomyopathy even when occlusive epicardial coronary arte-
rial disease cannot be demonstrated angiographically (25). In 
addition, it has been shown that impaired CFR may lead to myo-
cardial ischemia, progression of LV dysfunction, congestive 
heart failure (34) and increased mortality (17) in patients with 
dilated cardiomyopathy. The association of RDW with subclini-
cal inflammation and oxidative stress markers (such as uric 
acid) suggests a close association with IDC patients. Since 
subclinical inflammation and oxidative stress markers that 
cause coronary microvascular dysfunction are effective in 
pathophysiological processes. 
Study limitations
The main limitation of our study is the relatively small sample size.
Conclusion
The present study used second harmonic TTDE for CFR 
determination of LAD coronary artery to evaluate the possible 
association between RDW and CFR in patients with IDC. The 
main findings of the study are that IDC patients with lower CFR 
have increased RDW and an independent association between 
RDW levels and CFR is evident in patients with IDC. 
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